How the ARTiFACTS and Notre Dame collaboration addresses substandard or falsified drugs in pharmaceutical supply chains, a global public health challenge
Posted on
Today, virtually every country is impacted by substandard or falsified drugs entering their system, from generics to more expensive treatments for cancer and pain management. And the full extent of this problem is not known – but the WHO conservatively estimates that 200 million people are affected. Up to 2 billion people around the world…